Lenzing's Balance Sheet Is Fixed; Heiligenkreuz Still Isn't
Published on 11/03/2026 at 22:21 | Editorial boerse-global.de
Lenzing has closed the financial chapter of its restructuring. The operational one remains wide open, and the gap between the two was on full display this week.
The Austrian fibre maker confirmed in a mandatory disclosure that its total voting rights now stand at 73,374,542, with share capital of EUR 76,204,702.90 following its rights issue. The change took effect on 22 October.
That capital raise, wrapped up roughly two weeks ago, was fully underwritten and placed 34,756,362 new shares at an issue price of EUR 8.65 apiece. Gross proceeds came to about EUR 301.2 million. Investors subscribed for 34,411,626 shares through the subscription offer — a take-up rate of 99.0% — leaving the banks accompanying the deal to sell the remainder on the market.
Ownership Map Settles
Lenzing updated its shareholder structure on Thursday. The syndicate of B&C Group and Suzano S.A. continues to hold around 52.25% of voting rights. Suzano Holding S.A. picked up a direct stake of roughly 0.80% in the course of the raise, while Goldman Sachs Group is credited with 5.86% of Lenzing shares.
Should investors sell immediately? Or is it worth buying Lenzing?
The register also reflects a transfer of subscription rights inside the syndicate. According to a corrected voting-rights notification dated 28 October, Suzano International Trade GmbH passed rights for 1,757,754 new shares to B&C Zeta Zweite Holding GmbH, exercising the rest itself.
A Mill on Hold, Not Saved
Against that financial backdrop, the more consequential news broke on 22 October: the planned closure of the Heiligenkreuz plant has been pushed from the end of 2026 into the first quarter of 2027. A company spokesperson confirmed media reports. The delay buys time for a possible sale of the site as an alternative to shutting it down — but it does not constitute a solution.
Some 285 people work at Heiligenkreuz. Lenzing has been in contact with about 30 interested parties over a potential takeover, a sign that alternatives are being explored. The number of conversations, however, says nothing about whether a viable deal will emerge. Reading the postponement as a reprieve turns a possibility into an outcome.
The distinction matters because the rights issue and the plant question are two separate tasks. The capital increase is meant to shore up the balance sheet and support Lenzing's strategy — growth in nonwovens and a repositioning of the textile business. Raising money is one job; converting strategic goals into workable operating decisions is another. Owner continuity and economic execution sit side by side at Lenzing, not in place of each other.
Lenzing at a turning point? This analysis reveals what investors need to know now.
What to Watch
The next fixed date on the calendar is 5 November, when Lenzing publishes its third-quarter 2026 results between 15:00 and 16:00 CET.
Fresh capital and a stable majority provide the framework. They do not substitute for operational progress — both must still make it possible. For investors, the equity story here is about a corporate overhaul, not merely a financing transaction, and Heiligenkreuz is where the concrete decisions are still pending.
Ad
Lenzing Stock: New Analysis - 3 November
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
